These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 25615881)
1. The Cyclops for pulmonary delivery of aminoglycosides; a new member of the Twincer™ family. Hoppentocht M; Akkerman OW; Hagedoorn P; Frijlink HW; de Boer AH Eur J Pharm Biopharm; 2015 Feb; 90():8-15. PubMed ID: 25615881 [TBL] [Abstract][Full Text] [Related]
2. Physicochemical characterization and aerosol dispersion performance of organic solution advanced spray-dried microparticulate/nanoparticulate antibiotic dry powders of tobramycin and azithromycin for pulmonary inhalation aerosol delivery. Li X; Vogt FG; Hayes D; Mansour HM Eur J Pharm Sci; 2014 Feb; 52():191-205. PubMed ID: 24215736 [TBL] [Abstract][Full Text] [Related]
3. Physical Characterization of Tobramycin Inhalation Powder: I. Rational Design of a Stable Engineered-Particle Formulation for Delivery to the Lungs. Miller DP; Tan T; Tarara TE; Nakamura J; Malcolmson RJ; Weers JG Mol Pharm; 2015 Aug; 12(8):2582-93. PubMed ID: 26052676 [TBL] [Abstract][Full Text] [Related]
4. Design and in vitro performance testing of multiple air classifier technology in a new disposable inhaler concept (Twincer) for high powder doses. de Boer AH; Hagedoorn P; Westerman EM; Le Brun PP; Heijerman HG; Frijlink HW Eur J Pharm Sci; 2006 Jun; 28(3):171-8. PubMed ID: 16650739 [TBL] [Abstract][Full Text] [Related]
6. Preparation and characterization of spray-dried tobramycin powders containing nanoparticles for pulmonary delivery. Pilcer G; Vanderbist F; Amighi K Int J Pharm; 2009 Jan; 365(1-2):162-9. PubMed ID: 18782609 [TBL] [Abstract][Full Text] [Related]
7. Design, characterization, and aerosol dispersion performance modeling of advanced co-spray dried antibiotics with mannitol as respirable microparticles/nanoparticles for targeted pulmonary delivery as dry powder inhalers. Li X; Vogt FG; Hayes D; Mansour HM J Pharm Sci; 2014 Sep; 103(9):2937-2949. PubMed ID: 24740732 [TBL] [Abstract][Full Text] [Related]
8. Low powder mass filling of dry powder inhalation formulations. Eskandar F; Lejeune M; Edge S Drug Dev Ind Pharm; 2011 Jan; 37(1):24-32. PubMed ID: 20738180 [TBL] [Abstract][Full Text] [Related]
9. Minimal amounts of dipalmitoylphosphatidylcholine improve aerosol performance of spray-dried temocillin powders for inhalation. Cuvelier B; Eloy P; Loira-Pastoriza C; Ucakar B; Sanogo AA; Dupont-Gillain C; Vanbever R Int J Pharm; 2015 Nov; 495(2):981-90. PubMed ID: 26456267 [TBL] [Abstract][Full Text] [Related]
10. Spray dried amikacin powder for inhalation in cystic fibrosis patients: a quality by design approach for product construction. Belotti S; Rossi A; Colombo P; Bettini R; Rekkas D; Politis S; Colombo G; Balducci AG; Buttini F Int J Pharm; 2014 Aug; 471(1-2):507-15. PubMed ID: 24886692 [TBL] [Abstract][Full Text] [Related]
11. Dry powder inhaler formulation of high-payload antibiotic nanoparticle complex intended for bronchiectasis therapy: Spray drying versus spray freeze drying preparation. Yu H; Teo J; Chew JW; Hadinoto K Int J Pharm; 2016 Feb; 499(1-2):38-46. PubMed ID: 26757148 [TBL] [Abstract][Full Text] [Related]
12. Development of excipients free inhalable co-spray-dried tobramycin and diclofenac formulations for cystic fibrosis using two and three fluid nozzles. Marasini N; Sheikh Z; Wong CYJ; Hosseini M; Spicer PT; Young P; Xin Ong H; Traini D Int J Pharm; 2022 Aug; 624():121989. PubMed ID: 35809834 [TBL] [Abstract][Full Text] [Related]
13. Advanced spray-dried design, physicochemical characterization, and aerosol dispersion performance of vancomycin and clarithromycin multifunctional controlled release particles for targeted respiratory delivery as dry powder inhalation aerosols. Park CW; Li X; Vogt FG; Hayes D; Zwischenberger JB; Park ES; Mansour HM Int J Pharm; 2013 Oct; 455(1-2):374-92. PubMed ID: 23820131 [TBL] [Abstract][Full Text] [Related]
14. Carrier-free combination for dry powder inhalation of antibiotics in the treatment of lung infections in cystic fibrosis. Pilcer G; De Bueger V; Traina K; Traore H; Sebti T; Vanderbist F; Amighi K Int J Pharm; 2013 Jul; 451(1-2):112-20. PubMed ID: 23643509 [TBL] [Abstract][Full Text] [Related]
15. Multi-breath dry powder inhaler for delivery of cohesive powders in the treatment of bronchiectasis. Young PM; Salama RO; Zhu B; Phillips G; Crapper J; Chan HK; Traini D Drug Dev Ind Pharm; 2015 May; 41(5):859-65. PubMed ID: 24811055 [TBL] [Abstract][Full Text] [Related]
16. Computational fluid dynamics (CFD) assisted performance evaluation of the Twincer™ disposable high-dose dry powder inhaler. de Boer AH; Hagedoorn P; Woolhouse R; Wynn E J Pharm Pharmacol; 2012 Sep; 64(9):1316-25. PubMed ID: 22881443 [TBL] [Abstract][Full Text] [Related]
17. Spray-Dried PulmoSphere™ Formulations for Inhalation Comprising Crystalline Drug Particles. Weers JG; Miller DP; Tarara TE AAPS PharmSciTech; 2019 Feb; 20(3):103. PubMed ID: 30734187 [TBL] [Abstract][Full Text] [Related]
18. The Delivery of High-Dose Dry Powder Antibiotics by a Low-Cost Generic Inhaler. Parumasivam T; Leung SS; Tang P; Mauro C; Britton W; Chan HK AAPS J; 2017 Jan; 19(1):191-202. PubMed ID: 27679516 [TBL] [Abstract][Full Text] [Related]
19. Phospholipid-based pyrazinamide spray-dried inhalable powders for treating tuberculosis. Eedara BB; Tucker IG; Das SC Int J Pharm; 2016 Jun; 506(1-2):174-83. PubMed ID: 27091294 [TBL] [Abstract][Full Text] [Related]
20. Particle engineering of materials for oral inhalation by dry powder inhalers. II-Sodium cromoglicate. Nolan LM; Li J; Tajber L; Corrigan OI; Healy AM Int J Pharm; 2011 Feb; 405(1-2):36-46. PubMed ID: 21129460 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]